.png)
Carrot has launched Carrot Intelligence, a proprietary AI platform designed to deliver personalised, context-driven care decisions across fertility and family care. The announcement marks a significant step forward for one of the most data-rich platforms in the category and a signal of where the industry is heading.
Unlike most AI tools entering the healthcare space, which are built on generic models and public datasets, Carrot Intelligence runs on a different foundation entirely. The platform is powered by what the company describes as the largest proprietary clinical dataset in the fertility and family care category, spanning 195 countries and built over nearly a decade of serving millions of members clinically and financially. That dataset has processed over $1 billion in claims, giving the platform a depth of contextual intelligence that generic models simply cannot replicate.
"The context of care really matters, because if you don't understand the context, you actually can't optimally help the person achieve the best outcome. That's what Carrot Intelligence does."
— Tammy Sun, Founder and CEO of Carrot.
The platform is designed to reach members earlier in their journey, before problems escalate rather than after they do. A recent Carrot survey found that 89% of women say they would prefer less invasive fertility options over IVF, yet the current healthcare system is largely built to react to failure. Carrot Intelligence is designed to change that dynamic, using AI to surface earlier clinical and non-clinical interventions based on where each member is in their journey, what they're navigating and how they're most likely to engage.
Critically, the platform has been built with clinical governance at its core. Carrot's clinical team defines the care guidance framework and retains ownership of clinical decisions, with AI scaling delivery rather than replacing clinical judgement. The platform also does not train its proprietary foundation models on member-protected health information, a deliberate architectural choice that keeps compliance and privacy controls central to how Carrot Intelligence operates.
For plan sponsors, the implications are significant. Carrot serves more than 1,200 customers ranging from small businesses to Fortune 10 companies, as well as major payers including Cigna and Blue Cross Blue Shield Global Solutions. Carrot Intelligence is designed to bring greater transparency to how those plan sponsor dollars are spent, with AI that is accountable to real clinical and financial outcomes rather than engagement metrics alone.
The launch also signals the broader maturation of AI in women's health, moving from experimentation to infrastructure. Carrot isn't the only company making this shift, but it may be one of the best positioned to do so, given the scale and specificity of the dataset underpinning the platform.
Tammy Sun will be joining us at Women's Health Week USA 2026 on May 13–14 at the New York Academy of Medicine, where conversations about AI, data and the path from innovation to scale will be at the centre of the programme. The launch of Carrot Intelligence is exactly the kind of development that makes those conversations timely.
